Shares of Moderna Inc. have soared so much that the biotechnology companys valuation is unjustifiable on a fundamental basis, said analyst Geoff Meacham on Tuesday, as his analysis suggests the stock… [+2652 chars]
Modernas stock price is ridiculous, says BofA analyst – MarketWatch